Optimizing Dendritic Cell-Based Approaches for Cancer Immunotherapy
Dendritic cells (DC) are professional antigen-presenting cells uniquely suited for cancer immunotherapy. They induce primary immune responses, potentiate the effector functions of previously primed T-lymphocytes, and orchestrate communication between innate and adaptive immunity. The remarkable dive...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
YJBM
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257036/ |